CHA Stem Cell Institute
The CHA Stem Cell Institute researches both adult stem cell pipelines as well as embryonic stem cell pipelines in unison with the world’s leading universities and research scholars in order to be the leaders in curing various incurable diseases.
Patent
| No |
CONTENTS |
| 33 |
Cell delivery system for the cell therapy comprising cells derived from embrynic stem cells(10-2009-0028952) |
| 32 |
Pharmaceutical composition for prevention or treatment of bone diseases and differentiation methods inmesenchymal stem cellosteoblasts (10-2011-0014329) |
| 31 |
Production methods for lymphocytes including natural killer cells for targeting cancer cells, and pharmaceutical composition containing the same (10-2011-0010942) |
| 30 |
Production methods for lymphocytes including activated natural killer cells (10-2010-0025574) |
| 29 |
Mesenchymal Stem Cell-Mediated Autologous Dendritic Cells with Increased Immunosuppression (10-2008-0117836) |
| 28 |
Autologous Dendritic Cell Mediated by Photodynamic Therapy, Having the Ability to Suppress Tumor Growth (10-2007-0068524) |
| 27 |
Composition for obesity and diabetes protection containing phospholipids as PTP1B inhibitors (10-2004-0096446) |
| 26 |
Mass production techniques forerythrocyte in vitro (10-2010-0013493) |
| 25 |
Mass production techniques forerythrocyte in vitro (10-2011-0005306) |
| 24 |
Hyaluronic acid derivatives as cellular carriers and production methods for same (10-2006-0137422) |